According to the prospectus there was no specific use for option conversion at the time. The primary goal was to reward shareholders, and the potential funding is just icing on the cake. no doubt this funding (if options are converted) will find good use with the new strategy in place.
https://www.raceoncology.com/race-placement-closes-oversubscribed-bonus-option-issue-launched-for-shareholders/
- Forums
- ASX - By Stock
- RAC
- Ann: Zantrene highly effective in Melanoma preclinical study
Ann: Zantrene highly effective in Melanoma preclinical study, page-160
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.79 |
Change
-0.075(4.02%) |
Mkt cap ! $304.8M |
Open | High | Low | Value | Volume |
$1.86 | $1.86 | $1.76 | $348.2K | 192.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5612 | $1.77 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.79 | 3567 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5612 | 1.770 |
1 | 160 | 1.765 |
2 | 3718 | 1.760 |
2 | 2358 | 1.755 |
2 | 11905 | 1.750 |
Price($) | Vol. | No. |
---|---|---|
1.790 | 3567 | 1 |
1.795 | 30 | 1 |
1.830 | 1000 | 1 |
1.840 | 4543 | 2 |
1.890 | 7332 | 2 |
Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
Last
$1.78 |
  |
Change
-0.075 ( 5.38 %) |
|||
Open | High | Low | Volume | ||
$1.81 | $1.86 | $1.76 | 27553 | ||
Last updated 15.55pm 14/06/2024 ? |
Featured News
RAC (ASX) Chart |